Toggle light / dark theme

Can humans achieve biological immortality? Brent Nally (longevity) interview

Hey guys — you might like this interview I did with Brent Nally (CEO — Longevity Plan) about why humans can and should strive towards biological immortality. Very grateful for any subs to support the channel!


I interview Brent Nally, host of Lifespan News and CEO/co-founder of Longevity Plan, about the longevity movement and why he believes humans can and should strive for biological immortality. Covers scientific progress, the evolving longevity movement, why some oppose radical life extension and a brief section on Bitcoin.

Lifespan news: https://www.youtube.com/channel/UC-hyW-B6pWS8lPjZk4zLYcQ

Brent’s YouTube: https://www.youtube.com/channel/UCCwpkla04tVxHJUds2J2aqA

Will You Live To 200? Five Levels Of Breakthroughs In Longevity Research You Must Know About

As founder of Longevity Vision Fund, I am often asked about the most promising life extension breakthroughs, from early cancer diagnostics to human avatars and everything in between. The simple answer is that there are many — but that’s probably not the kind of answer you were looking for!

Instead, let’s look at the latest longevity breakthroughs working on each of the five major levels of biological organization (cell, tissue, organ, organ system and organism) and what they each aim to accomplish.

Aging fruit flies have impaired genetic responses to viral infections compared to young flies

In a study at The University of Alabama, aging fruit flies died faster than younger flies from a viral infection because of different genetic responses, lowering the older flies’ tolerance to the infection.

The findings published recently in G3: Genes, Genomes, Genetics add to the understanding of innate immunity, the first line of defense against infections, which is not fully understood in humans, and prove the fruit fly, Drosophila, is a good candidate for aging immunity studies that could lead to advancements in treating in older humans.

“We are living in times where there is a substantial increase in aging populations, and we know there is a decline of immune function in humans as we age,” said Dr. Stanislava Chtarbanova, UA assistant professor of biological sciences whose lab led the study. “This is the first study to use the fly for investigating age-dependent, anti-viral responses. Our lab can leverage this genetic model to study the underlying aging immunity.”

Low-Carb Diets for Longevity

Can low-carb diets like Keto help you live longer? I spent way too much time reading research papers and the answer seems to be…maybe.


Affiliate Disclaimer: Longevity Advice is reader-supported. When you buy something using links on our site, we may earn a few bucks.

I love bacon.

On a beach trip with some college friends a few years ago, I was put in charge of breakfast. I made sure to buy eight pounds of bacon (one for every person on the trip) for our three days at the beach house.

Quantifying Biological Age: Blood Test #2 in 2021

Paper references for Levine’s Phenotypic Age calculator and aging.ai:

An epigenetic biomarker of aging for lifespan and healthspan:
https://pubmed.ncbi.nlm.nih.gov/29676998/

Population Specific Biomarkers of Human Aging: A Big Data Study Using South Korean, Canadian, and Eastern European Patient Populations:
https://pubmed.ncbi.nlm.nih.gov/29340580/

Juan Williams — Emmy Award Winning Television Commentator, Radio Personality, Newspaper Columnist

Emmy award winning television commentator, radio personality, and newspaper columnist, juan williams, talking about inter-generational dynamics, ageism, and aging in america.


Progress, Potential, And Possibilities has the honor of being joined today by Emmy Award winning Television Commentator, Radio Personality, and Newspaper Columnist, Mr. Juan Williams.

Mr. Williams has been a Fox News Contributor since 1997 (including being a member of the nightly, current issue discussion show known as The Five), writes for several newspapers including The Washington Post, The New York Times, and The Wall Street Journal, and has been published in magazines such as The Atlantic Monthly and Time.

Mr. Williams was a senior news analyst for National Public Radio for 11 years and was at The Washington Post for 23 years, working as an editorial writer, op-ed columnist, White House correspondent and national correspondent.

Mr. Williams is an accomplished author with multiple books including Thurgood Marshall: American Revolutionary, Eyes on the Prize: America’s Civil Rights Years, and We the People: The Modern-Day Figures Who Have Reshaped and Affirmed the Founding Fathers’ Vision of America.

DNA building blocks regulate inflammation

Mitochondria are the energy suppliers of our body cells. These tiny cell components have their own genetic material, which triggers an inflammatory response when released into the interior of the cell. The reasons for the release are not yet known, but some cardiac and neurodegenerative diseases as well as the aging process are linked to the mitochondrial genome. Researchers at the Max Planck Institute for Biology of Aging and the CECAD Cluster of Excellence in Aging research have investigated the reasons for the release of mitochondrial genetic material and found a direct link to cellular metabolism: when the cell’s DNA building blocks are in short supply, mitochondria release their genetic material and trigger inflammation. The researchers hope to find new therapeutic approaches by influencing this metabolic pathway.

Our body needs energy—for every metabolic process, every movement and for breathing. This energy is produced in tiny components of our body , the so-called mitochondria. Unlike other cell components, mitochondria have their own genetic material, mitochondrial DNA. However, in certain situations, mitochondria release their DNA into the interior of the cell, causing a reaction from the cell’s own immune system and being associated with various diseases as well as the aging process. The reasons for the release of mitochondrial DNA are not yet known.

Young blood to old – where do the answers to aging lie?

“After hopefully demonstrating efficacy through the pilot study, Conboy says that plans are underway for a 200–300 person, placebo-controlled Phase 3 trial to prove the use of the plasma dilution as a technology that innovatively treats co-morbidities of aging.”

This could be the first bridge.


UC Berkeley’s Irina Conboy talks parabiosis, plasma dilution, and why young blood may not hold the all answers.

/* */